221 related articles for article (PubMed ID: 26223410)
21. Diabetic phenotype and prognosis of patients with heart failure and preserved ejection fraction in a real life cohort.
Lejeune S; Roy C; Slimani A; Pasquet A; Vancraeynest D; Vanoverschelde JL; Gerber BL; Beauloye C; Pouleur AC
Cardiovasc Diabetol; 2021 Feb; 20(1):48. PubMed ID: 33608002
[TBL] [Abstract][Full Text] [Related]
22. The Effect of Ranolazine on Glycemic Control: a Narrative Review to Define the Target Population.
Lisi D; Andrews E; Parry C; Hill C; Ombengi D; Ling H
Cardiovasc Drugs Ther; 2019 Dec; 33(6):755-761. PubMed ID: 31802311
[TBL] [Abstract][Full Text] [Related]
23. Pharmacological control of diabetes and hypertension comorbidity in the elderly: A study of "real world" data.
Foguet-Boreu Q; Violán C; López Jiménez T; Pons-Vigués M; Rodríguez-Blanco T; Valderas JM; Guisado Clavero M; Pujol-Ribera E
Prim Care Diabetes; 2017 Aug; 11(4):348-359. PubMed ID: 28457898
[TBL] [Abstract][Full Text] [Related]
24. Glycated haemoglobin does not accurately predict average capillary glucose in non insulin-treated type 2 diabetes: The PRISMA study experience.
Trevisan R; Bonizzoni E; Bosi E; Ceriello A; Cucinotta D; Giorgino F; Tiengo A; Scavini M
Nutr Metab Cardiovasc Dis; 2016 Feb; 26(2):169-70. PubMed ID: 26803592
[No Abstract] [Full Text] [Related]
25. Non-alcoholic fatty liver disease and type 2 diabetes: Importance of glycemic control.
Bloomgarden Z
J Diabetes; 2017 Aug; 9(8):722-723. PubMed ID: 28513098
[No Abstract] [Full Text] [Related]
26. Makes FLASH the difference between the intervention group and the treatment-as-usual group in an evaluation study of a structured education and treatment programme for flash glucose monitoring devices in people with diabetes on intensive insulin therapy: study protocol for a randomised controlled trial.
Schipfer M; Albrecht C; Ehrmann D; Haak T; Kulzer B; Hermanns N
Trials; 2018 Feb; 19(1):91. PubMed ID: 29402319
[TBL] [Abstract][Full Text] [Related]
27. Review of hemoglobin A(1c) in the management of diabetes.
Gallagher EJ; Le Roith D; Bloomgarden Z
J Diabetes; 2009 Mar; 1(1):9-17. PubMed ID: 20923515
[TBL] [Abstract][Full Text] [Related]
28. Influence of preprocedural glycemic control on clinical outcomes of endovascular therapy in diabetic patients with lower extremity artery disease: an analysis from a Korean multicenter retrospective registry cohort.
Cha JJ; Kim H; Ko YG; Choi D; Lee JH; Yoon CH; Chae IH; Yu CW; Lee SW; Lee SR; Choi SH; Koh YS; Min PK;
Cardiovasc Diabetol; 2020 Jun; 19(1):97. PubMed ID: 32571352
[TBL] [Abstract][Full Text] [Related]
29. Hypoglycaemia in patients with diabetes mellitus and renal impairment.
Hettige TS; Cooper ME
Diab Vasc Dis Res; 2017 Mar; 14(2):166-168. PubMed ID: 28128009
[No Abstract] [Full Text] [Related]
30. Evidence to Avoid Overtesting and Overuse in Diabetes Mellitus and Other Diseases.
Barry K; Slawson DC; Shaughnessy AF
Am Fam Physician; 2020 Nov; 102(10):583-584. PubMed ID: 33179893
[No Abstract] [Full Text] [Related]
31. Editorial overview: Endocrine and metabolic diseases Druggable diabetes: identification of therapeutic opportunities.
Persaud SJ; Bowe JE
Curr Opin Pharmacol; 2018 Dec; 43():iii-v. PubMed ID: 30446351
[No Abstract] [Full Text] [Related]
32. The effect of garlic on lipid profile and glucose parameters in diabetic patients: A systematic review and meta-analysis.
Shabani E; Sayemiri K; Mohammadpour M
Prim Care Diabetes; 2019 Feb; 13(1):28-42. PubMed ID: 30049636
[TBL] [Abstract][Full Text] [Related]
33. [Inhaled insulin].
Uchigata Y
Nihon Rinsho; 2002 Sep; 60 Suppl 9():534-41. PubMed ID: 12387047
[No Abstract] [Full Text] [Related]
34. A systematic review and meta-analysis of randomized controlled trials on the effects of magnesium supplementation on insulin sensitivity and glucose control.
Simental-Mendía LE; Sahebkar A; Rodríguez-Morán M; Guerrero-Romero F
Pharmacol Res; 2016 Sep; 111():272-282. PubMed ID: 27329332
[TBL] [Abstract][Full Text] [Related]
35. A view on the quality of diabetes care in Italy and the role of Diabetes Clinics from the 2018 ARNO Diabetes Observatory.
Bonora E; Cataudella S; Marchesini G; Miccoli R; Vaccaro O; Fadini GP; Martini N; Rossi E
Nutr Metab Cardiovasc Dis; 2020 Oct; 30(11):1945-1953. PubMed ID: 32998821
[TBL] [Abstract][Full Text] [Related]
36. Control of glycemia and blood pressure in British adults with diabetes mellitus and subsequent therapy choices: a comparison across health states.
McAlister FA; Lethebe BC; Lambe C; Williamson T; Lowerison M
Cardiovasc Diabetol; 2018 Feb; 17(1):27. PubMed ID: 29433515
[TBL] [Abstract][Full Text] [Related]
37. Outcomes after first-time lower extremity revascularization for chronic limb-threatening ischemia in insulin-dependent diabetic patients.
Darling JD; O'Donnell TFX; Deery SE; Norman AV; Vu GH; Guzman RJ; Wyers MC; Hamdan AD; Schermerhorn ML
J Vasc Surg; 2018 Nov; 68(5):1455-1464.e1. PubMed ID: 30360841
[TBL] [Abstract][Full Text] [Related]
38. J-curve relationship between long term glycemic control and mortality in diabetic patients with acute myocardial infarction undergoing percutaneous coronary intervention.
Choi IJ; Choo EH; Kim HJ; Lim S; Moon D; Lee KY; Hwang BH; Kim CJ; Park MW; Lee JM; Park CS; Kim HY; Yoo KD; Jeon DS; Chung WS; Kim MC; Jeong MH; Ahn Y; Chang K
Cardiovasc Diabetol; 2021 Dec; 20(1):234. PubMed ID: 34911555
[TBL] [Abstract][Full Text] [Related]
39. New Medications for the Treatment of Diabetes.
Garg SK; Brackett S; Reinicke T; Hirsch IB
Diabetes Technol Ther; 2020 Feb; 22(S1):S149-S173. PubMed ID: 32069157
[No Abstract] [Full Text] [Related]
40. Effects of Mobile Text Messaging on Glycemic Control in Patients With Coronary Heart Disease and Diabetes Mellitus: A Randomized Clinical Trial.
Huo X; Krumholz HM; Bai X; Spatz ES; Ding Q; Horak P; Zhao W; Gong Q; Zhang H; Yan X; Sun Y; Liu J; Wu X; Guan W; Wang X; Li J; Li X; Spertus JA; Masoudi FA; Zheng X
Circ Cardiovasc Qual Outcomes; 2019 Sep; 12(9):e005805. PubMed ID: 31474119
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
